drugset / Trial / NCT06078592
Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive
RandomizedParallel-groupSingle-blindTreatment
Summary
Comparison of Efficacy and Ocular Surface Disease Assessment between BRIDIN-plus Eye drops and Combigan Eye drops in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial
Timeline
- Start
- 2021-10-08
- Primary completion
- 2022-12-23
- Completion
- 2022-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brimonidine | Small molecule | 2 mg | Topical |
| Comparator | Timolol | Other / unclassified | 6.8 mg | Topical |